Astronics Corporation
ATROB
$23.60
-$2.80-10.61%
| Weiss Ratings | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.67 | |||
| Price History | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -10.61% | |||
| 30-Day Total Return | 28.89% | |||
| 60-Day Total Return | 46.90% | |||
| 90-Day Total Return | 37.61% | |||
| Year to Date Total Return | 46.90% | |||
| 1-Year Total Return | 37.69% | |||
| 2-Year Total Return | 73.15% | |||
| 3-Year Total Return | 87.30% | |||
| 5-Year Total Return | 219.78% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 77.66% | |||
| Price | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $26.40 | |||
| 52-Week Low Price | $14.86 | |||
| 52-Week Low Price (Date) | Dec 23, 2024 | |||
| 52-Week High Price (Date) | Mar 25, 2025 | |||
| Valuation | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 877.26M | |||
| Enterprise Value | 1.06B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.47 | |||
| Earnings Per Share Growth | -42.87% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.17 | |||
| Price/Book (Q) | 3.64 | |||
| Enterprise Value/Revenue (TTM) | 1.41 | |||
| Price | $23.60 | |||
| Enterprise Value/EBITDA (TTM) | 22.77 | |||
| Enterprise Value/EBIT | 45.35 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 35.26M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 716 805 1599 | |||
| Address | 130 Commerce Way East Aurora, NY 14052 | |||
| Website | www.astronics.com | |||
| Country | United States | |||
| Year Founded | 1968 | |||
| Profitability | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 3.10% | |||
| Profit Margin | -2.03% | |||
| Management Effectiveness | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.40% | |||
| Return on Equity | -- | |||
| Income Statement | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 795.43M | |||
| Total Revenue (TTM) | 795.43M | |||
| Revenue Per Share | $22.56 | |||
| Gross Profit (TTM) | 168.34M | |||
| EBITDA (TTM) | 49.14M | |||
| EBIT (TTM) | 24.67M | |||
| Net Income (TTM) | -16.22M | |||
| Net Income Avl. to Common (TTM) | -16.22M | |||
| Total Revenue Growth (Q YOY) | 6.78% | |||
| Earnings Growth (Q YOY) | -140.60% | |||
| EPS Diluted (TTM) | -0.47 | |||
| EPS Diluted Growth (Q YOY) | -140.29% | |||
| Balance Sheet | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 9.29M | |||
| Cash Per Share (Q) | $0.26 | |||
| Total Current Assets (Q) | 426.17M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 256.10M | |||
| Current Ratio (Q) | 2.729 | |||
| Book Value Per Share (Q) | $7.26 | |||
| Total Assets (Q) | 648.76M | |||
| Total Current Liabilities (Q) | 156.15M | |||
| Total Debt (Q) | 194.00M | |||
| Total Liabilities (Q) | 392.67M | |||
| Total Common Equity (Q) | 256.10M | |||
| Cash Flow | ATROB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -8.43M | |||
| Cash from Financing (TTM) | -14.53M | |||
| Net Change in Cash (TTM) | 7.12M | |||
| Levered Free Cash Flow (TTM) | 19.66M | |||
| Cash from Operations (TTM) | 30.57M | |||
